Frec Markets Inc’s United Therapeutics UTHR Stock Holding History

Frec Markets Inc’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Buy	626 +87	+16%	+$49K	0.03%	676
2026 Q1	$320K	Buy	+539	New	+$268K	0.05%	402

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Frec Markets Inc's UTHR Position: Q2 2026 in Review

Frec Markets Inc increased its United Therapeutics (UTHR) stake by 16% in Q2 2026, buying an estimated $49K and bringing the position to 626 shares worth $339K. The position accounts for 0.03% of the portfolio, ranked #676.

Frec Markets Inc first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Frec Markets Inc held 626 shares of United Therapeutics worth $339K as of Q2 2026.
Frec Markets Inc bought 87 United Therapeutics shares in Q2 2026, an estimated $49K.
United Therapeutics made up 0.03% of Frec Markets Inc's portfolio in Q2 2026, its #676 holding.
Frec Markets Inc first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Frec Markets Inc's 13F filing for Q2 2026, filed 13 Aug 2026.